476 related articles for article (PubMed ID: 27927678)
21. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma.
Han JW; Lee CS; Hahn SM; Ahn WK; Kim HS; Yun H; Lee SC; Kim BM; Kim DJ; Lyu CJ
Cancer Res Treat; 2023 Jan; 55(1):270-278. PubMed ID: 35609621
[TBL] [Abstract][Full Text] [Related]
22. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
24. Alternated intra-arterial and intravitreal chemotherapy for advanced intraocular retinoblastoma: preliminary successful results without systemic chemotherapy.
De Francesco S; Galluzzi P; Bracco S; Menicacci F; Motolese E; Hadjistilianou T
Int Ophthalmol; 2015 Dec; 35(6):887-95. PubMed ID: 26416040
[TBL] [Abstract][Full Text] [Related]
25. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
[TBL] [Abstract][Full Text] [Related]
26. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
Abramson DH; Dunkel IJ; Brodie SE; Marr B; Gobin YP
Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
[TBL] [Abstract][Full Text] [Related]
27. Globe salvage treatment in group D and group E retinoblastoma.
Hussain AK; Rahul RA; Carlos RL; Francisco ZM; María GL; Flavia P; Chiara B; Davide B
Rom J Ophthalmol; 2021; 65(1):20-24. PubMed ID: 33817429
[No Abstract] [Full Text] [Related]
28. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
29. Intra-arterial chemotherapy for retinoblastoma: First Indian report.
Rishi P; Sharma T; Koundanya V; Bansal N; Saravanan M; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2015 Apr; 63(4):331-4. PubMed ID: 26044473
[TBL] [Abstract][Full Text] [Related]
30. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL
Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
[TBL] [Abstract][Full Text] [Related]
32. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
34. Intra-arterial chemotherapy for retinoblastoma: Our first three-and-a-half years' experience in Malaysia.
Liu CC; Mohmood A; Hamzah N; Lau JH; Khaliddin N; Rahmat J
PLoS One; 2020; 15(5):e0232249. PubMed ID: 32357178
[TBL] [Abstract][Full Text] [Related]
35. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: a retrospective study.
Chen M; Jiang H; Zhang J; Shen G; Jiang Y; Li H; Liu Z
Acta Ophthalmol; 2017 Sep; 95(6):613-618. PubMed ID: 27874261
[TBL] [Abstract][Full Text] [Related]
36. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
[TBL] [Abstract][Full Text] [Related]
37. Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies.
Chen M; Zhao J; Xia J; Liu Z; Jiang H; Shen G; Li H; Jiang Y; Zhang J
PLoS One; 2016; 11(8):e0160873. PubMed ID: 27504917
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients.
Daniels AB; Froehler MT; Kaczmarek JV; Bogan CM; Santapuram PR; Pierce JM; Chen SC; Schremp EA; Boyd KL; Tao YK; Calcutt MW; Koyama T; Richmond A; Friedman DL
Transl Vis Sci Technol; 2021 Sep; 10(11):10. PubMed ID: 34495330
[TBL] [Abstract][Full Text] [Related]
39. Salvage Intra-arterial Chemotherapy for Recurrent or Persistent Intraocular Retinoblastoma: A Study of 24 Eyes.
Verma R; Adewara BA; Reddy Palkonda VA; Reddy S; Kaliki S
Ophthalmol Retina; 2023 Mar; 7(3):275-281. PubMed ID: 36195261
[TBL] [Abstract][Full Text] [Related]
40. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
